0
Protagenic Therapeutics, Inc.
- 1-10 Employees
- Based in New York City, New York
Protagenic Therapeutics, Inc. (OTCQB: PTIX) is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, and other disorders.
Protagenic Therapeutics, Inc.
Most Recent Annual Report
Protagenic Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
